XLON
RSW
Market cap4.62bUSD
Jul 09, Last price
4,734.00GBP
1D
3.23%
1Q
25.37%
Jan 2017
87.26%
Name
Renishaw PLC
Chart & Performance
P/E
41.11
P/S
4.83
EPS
1.15
Div Yield, %
1.56%
Shrs. gr., 5y
-0.01%
Rev. gr., 5y
6.95%
Revenues
713m
+3.15%
Net income
84m
-13.55%
CFO
148m
+19.20%
Dividend
Oct 30, 202561.3 GBP/sh
Notes
No notes on this company yet
Write a private note on this company, for your eyes only
Profile
Renishaw plc is a British engineering and scientific technology enterprise, established in 1973, that operates globally. The company specializes in the conception, production, distribution, and maintenance of advanced metrology and healthcare innovations. Its diverse metrology offerings encompass coordinate measuring machine (CMM) solutions, machine tool probes and associated software, precision measurement systems, various gauging instruments, fixtures, styli, and a range of optical, magnetic, and interferometric laser encoders. Renishaw also provides additive manufacturing platforms, vacuum casting machines for plastics and metals, and mapping sensors. Within its healthcare division, products include dental scanning technology, neurosurgical robotics, planning software, drug delivery apparatus, advanced Raman microscopes, custom craniomaxillofacial implants, and analytical devices. Furthermore, the company extends its services to include asset financing and travel arrangements. Renishaw's clientele spans numerous critical sectors, such as aerospace, automotive, consumer electronics, medical, energy, heavy industry, and scientific research, alongside agriculture, construction, and precision manufacturing.
Valuation
Title GBP in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY |
|---|---|---|---|---|---|---|---|---|---|
| 2025‑06 | 2024‑06 | 2023‑06 | 2022‑06 | 2021‑06 | 2020‑06 | 2019‑06 | 2018‑06 | 2017‑06 | |
| Income | |||||||||
Revenues | |||||||||
Cost of revenue | |||||||||
Unusual Expense (Income) | |||||||||
NOPBT | |||||||||
NOPBT Margin | |||||||||
Operating Taxes | |||||||||
Tax Rate | |||||||||
NOPAT | |||||||||
Net income | |||||||||
Dividends | |||||||||
Dividend yield | |||||||||
Proceeds from repurchase of equity | |||||||||
BB yield | |||||||||
| Debt | |||||||||
Debt current | |||||||||
Long-term debt | |||||||||
Deferred revenue | |||||||||
Other long-term liabilities | |||||||||
Net debt | |||||||||
| Cash flow | |||||||||
Cash from operating activities | |||||||||
CAPEX | |||||||||
Cash from investing activities | |||||||||
Cash from financing activities | |||||||||
FCF | |||||||||
| Balance | |||||||||
Cash | |||||||||
Long term investments | |||||||||
Excess cash | |||||||||
Stockholders' equity | |||||||||
Invested Capital | |||||||||
ROIC | |||||||||
ROCE | |||||||||
| EV | |||||||||
Common stock shares outstanding | |||||||||
Price | |||||||||
Market cap | |||||||||
EV | |||||||||
EBITDA | |||||||||
EV/EBITDA | |||||||||
Interest | |||||||||
Interest/NOPBT | |||||||||